News

Join Us For A Webinar: A Major New, Clinically-Supported Weight Management Ingredient Building a Weight Loss Brand that Consumers Can Trust

September 27, 2016
Join Us For A Webinar: A Major New, Clinically-Supported Weight Management Ingredient Building a Weight Loss Brand that Consumers Can Trust

TIME: 1:30 PM EDT
PLACE: Click here to register

Come learn about SLIMVANCE Core Slimming Complex. SLIMVANCE’s patented approach works at multiple levels by inhibiting the accumulation of fat into fat cells (lipogenesis) and enhancing the body’s ability to break down fat cells (lipolysis). A 2016 16-week double-blind, placebo controlled study of SLIMVANCE, conducted with a healthy population of overweight men and women, sets new standards for communicating efficacy to consumers and regulatory agencies in the weight management category – because of its size, its length, its use of non-obese subjects and its design and execution. Consistent body weight reductions were observed throughout the 16-week trial – starting with statistically significant weight loss at 2 weeks, with a total weight loss of nearly 12 lbs. by the end of the study. These overweight subjects taking SLIMVANCE lost 2 inches in waist circumference in the study. This trial was designed with the latest guidance from regulatory agencies in mind, but also to help give our customers confidence in the performance of SLIMVANCE across a broad section of the population